Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension

SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 265: 3255–3264, 1991.

Dahlöf B., Lindholm L.H., Hansson L., Schersten B., Ekbom T., Nester P.O.: Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP- Hypertension). Lancet 338: 1281–1285, 1991.

MRC Working Party: Medical Research Council Trial of treatment of hypertension in older adults: principal results. BMJ 304: 405–412, 1992.

Garland C., Barrett-Connor E., Suarez L., Criqui M.M.: Isolated systolic hypertension and mortality after age 60 years. Am. J. Epidemiol. 118: 365–376, 1983.

Amery A., Birkenhäger W., Brixko R., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F., Forte J., Hamdy R., Henry J.F., Joossens J.V., Leonetti G., Lund-Johansen P., O’Malley K., Petrie J.C., Strasser T., Tuomilehto J., Williams B.: Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over age 60. Lancet 2: 589–592, 1986.

Rutan G.H., Kuller L.H., Neaton J.D., Wentworth D.N., Mc-Donald R.H., Smith W.M.: Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 77: 504–514, 1988.

Morgensten N., Byyny R.L.: Epidemiology of hypertension in the elderly. Drugs Aging 2: 222–242, 1992.

Williamson J., Chopin J.M.: Adverse reactions to prescribed drugs in the elderly: A multicenter investigation. Age and Ageing 9: 73–80, 1980.

Cafiero M., Giasi M.: Long-term (12 months) treatment with lercanidipine in patients with mild to moderate hypertension. J. Cardiovasc. Pharmacol. 29 (Suppl. 2): S46–S50, 1997.

Amery A., Birkenhäger W., Bulpitt C.J., Clement D., De Leeuw P., Dollery C.T., Fagard R., Fletcher A., Forette F., Leonetti G., O’Brian E.T., O’Malley K., Rodicio J.L., Rosenfeld J., Staessen J., Strasser T., Terzoli L., Thijs L., Tuomilehto J., Webster J.: Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization. Aging Clin. Exp. Res. 3: 287–302, 1991..

Circo A.: Active dose finding for lercanidipine in a double-blind, placebo-controlled design in patients with mild to moderate hypertension. J. Cardiovasc. Pharmacol. 29 (Suppl. 2): S21–S25, 1997..

Barbagallo Sangiorgi G., Putignano E., Calcara L., Barbagallo M.: Efficacy and tolerability of lercanidipine vs captopril in patients with mild to moderate hypertension in a double-blind controlled study. J. Cardiovasc. Pharmacol. 29 (Suppl. 2): S36–S39, 1997.